EP0832126A4 - G-protein receptor htnad29 - Google Patents
G-protein receptor htnad29Info
- Publication number
- EP0832126A4 EP0832126A4 EP95923763A EP95923763A EP0832126A4 EP 0832126 A4 EP0832126 A4 EP 0832126A4 EP 95923763 A EP95923763 A EP 95923763A EP 95923763 A EP95923763 A EP 95923763A EP 0832126 A4 EP0832126 A4 EP 0832126A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- htnad29
- protein receptor
- receptor
- protein
- receptor htnad29
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Plant Pathology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1995/007288 WO1996039442A1 (en) | 1995-06-06 | 1995-06-06 | G-protein receptor htnad29 |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0832126A1 EP0832126A1 (en) | 1998-04-01 |
EP0832126A4 true EP0832126A4 (en) | 2000-01-12 |
Family
ID=22249278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP95923763A Withdrawn EP0832126A4 (en) | 1995-06-06 | 1995-06-06 | G-protein receptor htnad29 |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0832126A4 (en) |
JP (1) | JPH11506341A (en) |
KR (1) | KR19990022531A (en) |
CN (1) | CN1147505C (en) |
AU (1) | AU714642B2 (en) |
CA (1) | CA2221706A1 (en) |
WO (1) | WO1996039442A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6221627B1 (en) | 1997-02-24 | 2001-04-24 | Smithkline Beecham Corporation | cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
US6555339B1 (en) * | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
US6733990B1 (en) | 1999-08-03 | 2004-05-11 | Millennium Pharmaceuticals, Inc. | Nucleic acid encoding 15571, a GPCR-like molecule of the secretin-like family |
EP2264068A1 (en) * | 1998-10-13 | 2010-12-22 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human G protein-coupled receptors |
US6919176B2 (en) | 2001-05-07 | 2005-07-19 | Amgen Inc. | Polypeptides and nucleic acids associated with cancer |
AU2003206749A1 (en) * | 2002-02-01 | 2003-09-02 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with the gpr65 receptor |
MXPA05013721A (en) | 2003-06-20 | 2006-03-08 | Novartis Ag | Proton-sensing g-protein coupled receptors and dna sequences thereof. |
WO2008101354A1 (en) * | 2007-02-22 | 2008-08-28 | Merck Frosst Canada Ltd | Gpr65 as a therapeutic target in allergic airway inflammation |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992001810A1 (en) * | 1990-07-19 | 1992-02-06 | Lerner Michael R | Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
WO1993007294A1 (en) * | 1991-10-01 | 1993-04-15 | The United States Of America, Represented By The Secretary, Department Of Health And Human Service | A method of identifying ligands and antagonists of ligands |
WO1993012134A1 (en) * | 1991-12-11 | 1993-06-24 | President And Fellows Of Harvard College | Diagnosis of hereditary retinal degenerative diseases |
WO1994005695A1 (en) * | 1992-09-10 | 1994-03-17 | New York University | Polypeptides of g-coupled receptor proteins, and compositions and methods thereof |
WO1996027603A1 (en) * | 1995-03-03 | 1996-09-12 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of immune disorders |
-
1995
- 1995-06-06 CA CA002221706A patent/CA2221706A1/en not_active Abandoned
- 1995-06-06 KR KR1019970709012A patent/KR19990022531A/en not_active Application Discontinuation
- 1995-06-06 JP JP9500379A patent/JPH11506341A/en active Pending
- 1995-06-06 EP EP95923763A patent/EP0832126A4/en not_active Withdrawn
- 1995-06-06 AU AU28204/95A patent/AU714642B2/en not_active Ceased
- 1995-06-06 WO PCT/US1995/007288 patent/WO1996039442A1/en not_active Application Discontinuation
- 1995-06-06 CN CNB951979256A patent/CN1147505C/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992001810A1 (en) * | 1990-07-19 | 1992-02-06 | Lerner Michael R | Methods of identifying compounds that act as agonists or antagonists for proteins involved in signal transduction |
WO1993007294A1 (en) * | 1991-10-01 | 1993-04-15 | The United States Of America, Represented By The Secretary, Department Of Health And Human Service | A method of identifying ligands and antagonists of ligands |
WO1993012134A1 (en) * | 1991-12-11 | 1993-06-24 | President And Fellows Of Harvard College | Diagnosis of hereditary retinal degenerative diseases |
WO1994005695A1 (en) * | 1992-09-10 | 1994-03-17 | New York University | Polypeptides of g-coupled receptor proteins, and compositions and methods thereof |
WO1996027603A1 (en) * | 1995-03-03 | 1996-09-12 | Millennium Pharmaceuticals, Inc. | Compositions and methods for the treatment and diagnosis of immune disorders |
Non-Patent Citations (6)
Title |
---|
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002121362, Database accession no. T87010 * |
DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002121363, Database accession no. T86932 * |
DATABASE SWISSPROT 1 January 1900 (1900-01-01), XP002121817, Database accession no. P32250 * |
LEE N.H. AND KERLAVAGE A.R.: "Molecular biology of G-protein-coupled receptors", DRUG NEWS AND PERSPECTIVES, vol. 6, no. 7, 1 September 1993 (1993-09-01), pages 488 - 497, XP000677175, ISSN: 0214-0934 * |
OLIVEIRA L. ET AL.: "A common motif in G-protein-coupled seven transmembrane helix receptors", JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, vol. 7, no. 6, 1 December 1993 (1993-12-01), pages 649 - 658, XP002050853, ISSN: 0920-654X * |
See also references of WO9639442A1 * |
Also Published As
Publication number | Publication date |
---|---|
KR19990022531A (en) | 1999-03-25 |
CA2221706A1 (en) | 1996-12-12 |
JPH11506341A (en) | 1999-06-08 |
AU2820495A (en) | 1996-12-24 |
EP0832126A1 (en) | 1998-04-01 |
CN1147505C (en) | 2004-04-28 |
CN1193980A (en) | 1998-09-23 |
WO1996039442A1 (en) | 1996-12-12 |
AU714642B2 (en) | 2000-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU7692996A (en) | Receptor antagonists | |
HU9601529D0 (en) | Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists | |
EP0858444A4 (en) | Cyclopentyl tachykinin receptor antagonists | |
IL125717A0 (en) | Il-8 receptor antagonists | |
EP0815137A4 (en) | Human g-protein chemokine receptor hdgnr10 | |
EP0832125A4 (en) | Human g-protein receptor hgber32 | |
EP0817800A4 (en) | Human g-protein coupled receptors | |
ZA963535B (en) | Adhesion receptor antagonists | |
EP0853629A4 (en) | Hepadnavirus receptor | |
EP0871667A4 (en) | G-protein coupled receptor | |
GB9517098D0 (en) | Receptor | |
EP0832122A4 (en) | Human g-protein receptor hpraj70 | |
EP0832126A4 (en) | G-protein receptor htnad29 | |
EP0841925A4 (en) | Endothelin receptor antagonists | |
EP0835264A4 (en) | Human g-protein receptor hcegh45 | |
HU9600333D0 (en) | Adhesive receptor antagonists | |
AU4753496A (en) | Human g-protein coupled receptor | |
AU2698995A (en) | G-protein receptor hibeb69 | |
EP0841926A4 (en) | Endothelin receptor antagonists | |
EP0812329A4 (en) | Human g-protein coupled receptor | |
EP0836621A4 (en) | Novel human g-protein coupled receptor | |
EP0833846A4 (en) | Human g-protein coupled receptor (hetgq23) | |
EP0770094A4 (en) | Modified g-protein coupled receptors | |
EP0871668A4 (en) | Human g-protein receptor hibef51 | |
EP0859787A4 (en) | G-protein coupled receptor hnfds78 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19971230 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19991129 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20020416 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20060607 |